Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
During the last few weeks Roche has been in hot pursuit of sources of innovation, including the proposed acquisition of partner Genentech. In the same week it acquired antibody screening company Arius, RNAi company Mirus and made three more deals that the company will not announce. Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi sat down with the PharmAsia News Australia bureau to discuss what Roche is looking for in its partners and its current partnership with Roche's Japan partner Chugai.
You may also be interested in...
Chugai To Remain Unscathed By Roche's Internal Restructuring And Cost-cutting Measures
TOKYO - Roche Group is in the process of reviewing and implementing a group-wide productivity and cost reduction program, but Japanese partner Chugai will not be directly impacted by the initiative, according to Roche's CEO
Chugai To Remain Unscathed By Roche's Internal Restructuring And Cost-cutting Measures
TOKYO - Roche Group is in the process of reviewing and implementing a group-wide productivity and cost reduction program, but Japanese partner Chugai will not be directly impacted by the initiative, according to Roche's CEO
Chugai To Remain Unscathed By Roche's Internal Restructuring And Cost-cutting Measures
Roche CEO Schwan also informed analysts that the company is not considering expanding its business into other areas such as a pharmaceutical generics or biosimilars.